BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 15, 2003
View Archived Issues
Advectus acquires option for nanopharmaceutical for Alzheimer's disease
Read More
Cell Therapeutics Scandinavia and Tanabe enter stem cell collaboration
Read More
Probactrix controls antibiotic-associated diarrhea in clinical study
Read More
Novel 5-HT6 receptor ligands claimed by GSK researchers
Read More
Pierre Fabre presents new alpha2-adrenoceptor modulators with potential in AD therapy
Read More
BMS scientists prepare and test new anti-HIV agents
Read More
Novel p38 inhibitors, their preparation and use covered by GSK patent
Read More
Roche identifies new DPP-IV inhibitors
Read More
AstraZeneca claims JNK inhibitors for use in AD and other disorders
Read More
Humira approved in E.U. for rheumatoid arthritis
Read More
Raptiva recommended for approval by advisory committee
Read More
Maxalt launched this month in Japan for migraine Rx
Read More
Potent antagonist of human glucagon receptor presented at ACS meeting
Read More
Selective ERbeta agonist endowed with potent oral antiinflammatory activity
Read More
OncoGenex and Isis expand antisense drug development partnership
Read More
AVE-5997, a selective, orally active dopamine D3 antagonist, characterized at ACS meeting
Read More
Regeneron to advance phase III Axokine program in obesity
Read More
Benicar HCT now available in U.S.
Read More
Javlor enters two new phase III trials in NSCLC and bladder cancer
Read More
BMS designs series of potent and selective Itk inhibitors as potential immunosuppressants
Read More
Enrollment completed in phase I breast cancer trial for HER-2 AutoVac Protein vaccine
Read More
Merck presents synthesis, SAR for a series of imidazole acetic acid TAFI inhibitors
Read More
FDA accepts for filing diquafosol NDA for dry eye
Read More
Phase III results for Genasense plus chemotherapy in malignant melanoma
Read More
Genzyme expands access to Myozyme
Read More
SBIR grant supports smallpox therapeutic development efforts at Aphios
Read More
New fluoroquinolone active against multidrug-resistant Gram-positive pathogens
Read More